NEW YORK — Pfizer Inc. (NYSE:PFE) today announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration… Read More
VANCOUVER and TORONTO – TELUS Corporation has announced the completion of the previously disclosed $2.3 billion acquisition of LifeWorks Inc., a world leader in providing digital and in-person solutions that… Read More
Ondine Biomedical reports successful topline data from Phase 2 nasal photodisinfection trial Results show a single, 5-minute treatment of nasal photodisinfection significantly reduces Staphylococcus aureus, a major cause of surgical site… Read More
Late-breaking Dupixent® (dupilumab) data at ERS 2022 show consistent efficacy and safety profile for up to two years in children aged 6 to 11 years with moderate-to-severe asthma Results from the longest global Phase 3 open-label extension trial in this age group in asthma show sustained improvement… Read More
Roche Canada is thrilled to welcome Brigitte Nolet as President and CEO for Roche Canada Pharma. As a Canadian citizen who hails from Welland, Ontario, Brigitte has held a number… Read More
